Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Neoplasms unspecified malignancy and site unspecified NEC
ADR ID BADD_A03014
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.02      Neoplasms unspecified malignancy and site unspecified NEC
Description Not Available
MedDRA Code 10029111
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01966Ropinirole--
BADD_D01989Saquinavir mesylate--
BADD_D02002Selegiline--
BADD_D02007Semaxanib--
BADD_D02010Sertraline0.000051%
BADD_D02011Sertraline hydrochloride--
BADD_D02016Sibutramine--
BADD_D02018Sildenafil0.000161%
BADD_D02026Simvastatin0.000022%
BADD_D02028Sirolimus0.000268%
BADD_D02029Sitagliptin0.000080%
BADD_D02031Sitaxentan--
BADD_D02058Sorafenib0.000336%
BADD_D02097Sulindac0.000700%
BADD_D02100Sunitinib0.061751%
BADD_D02105Tacrolimus0.000891%
BADD_D02107Tafamidis0.002692%
BADD_D02111Tamoxifen0.000238%
BADD_D02112Tamoxifen citrate--
BADD_D02140Tegaserode--
BADD_D02150Temozolomide0.004914%
BADD_D02153Teniposide--
BADD_D02165Teriflunomide0.000603%
BADD_D02170Testosterone--
BADD_D02173Testosterone propionate--
BADD_D02192Thalidomide0.000362%
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02213Tibolone--
BADD_D02217Tigecycline0.000049%
The 8th Page    First    Pre   8 9 10 11    Next   Last    Total 11 Pages